The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
Zacks.com on MSN1d
RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded UseUltragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
AquaSculpt is a natural weight loss supplement created by Dr. Blaine Schilling, a top New York City doctor specializing in weight loss. It's based on an "odd ice hack" theory that helps adults of all ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback